View Item 

Show simple item record

Rare bleeding disorders
dc.contributor.authorPeyvandi, F.en_US
dc.contributor.authorKaufman, R. J.en_US
dc.contributor.authorSeligsohn, U.en_US
dc.contributor.authorSalomon, O.en_US
dc.contributor.authorBolton-Maggs, P. H. B.en_US
dc.contributor.authorSpreafico, M.en_US
dc.contributor.authorMenegatti, M.en_US
dc.contributor.authorPalla, R.en_US
dc.contributor.authorSiboni, S.en_US
dc.contributor.authorMannucci, P. M.en_US
dc.date.accessioned2010-06-01T18:28:41Z
dc.date.available2010-06-01T18:28:41Z
dc.date.issued2006-07en_US
dc.identifier.citationPEYVANDI, F.; KAUFMAN, R. J.; SELIGSOHN, U.; SALOMON, O.; BOLTON-MAGGS, P. H. B.; SPREAFICO, M.; MENEGATTI, M.; PALLA, R.; SIBONI, S.; MANNUCCI, P. M. (2006). "Rare bleeding disorders." Haemophilia 12(s3): 137-142. <http://hdl.handle.net/2027.42/71685>en_US
dc.identifier.issn1351-8216en_US
dc.identifier.issn1365-2516en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71685
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16684009&dopt=citationen_US
dc.format.extent121933 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 The Authors Journal compilation 2006 Blackwell Publishing Ltden_US
dc.subject.otherRare Bleeding Disordersen_US
dc.subject.otherRBDsen_US
dc.subject.otherGeneticsen_US
dc.subject.otherTreatmenten_US
dc.subject.otherGuidelinesen_US
dc.subject.otherInternational Registry of RBDsen_US
dc.subject.otherRBDDen_US
dc.titleRare bleeding disordersen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationother* Department of Medicine and Medical Specialities, IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, University of Milan, Milan, Italyen_US
dc.contributor.affiliationotherDepartment of Biological Chemistry, Howard Hughes Medical Institute, University of Michigam Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherThe Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Israelen_US
dc.contributor.affiliationotherDepartment of Clinical Haematology, Manchester Royal Infirmary, Manchester, UKen_US
dc.contributor.affiliationotherDepartment of Medicine and Medical Specialities, IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Univeristy of Milan, Milan, Italy.en_US
dc.identifier.pmid16684009en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71685/1/j.1365-2516.2006.01271.x.pdf
dc.identifier.doi10.1111/j.1365-2516.2006.01271.xen_US
dc.identifier.sourceHaemophiliaen_US
dc.identifier.citedreferenceTuddenham EGD, Cooper DN. The Molecular Genetics of Haemostasis and Its Inherited Disorders. Oxford, United Kingdom: Oxford Medical Publications, 1994 (Oxford Monography on Medical Genetics No. 25).en_US
dc.identifier.citedreferencePeyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8: 308 – 21.en_US
dc.identifier.citedreferenceMannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243 – 52.en_US
dc.identifier.citedreferenceZhang B, Kaufman RJ, Ginsburg D. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem 2005; 280: 25881 – 6.en_US
dc.identifier.citedreferenceMacLennan S, Barbara JA. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol 2006; 19: 169 – 89.en_US
dc.identifier.citedreferenceChandy M. Management of hemophilia with minimal factor replacement in developing countries: role of ancillary therapy. Semin Thromb Hemost 2005; 31: 501 – 6.en_US
dc.identifier.citedreferenceSalomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005; 16: 37 – 41.en_US
dc.identifier.citedreferenceSalomon O, Steinberg DM, Seligsohn U. Variable bleeding manifestation during different types of surgery in patients with severe factor XI deficiency support tailored replacement therapy. Submitted for publication 2006.en_US
dc.identifier.citedreferenceAsakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153 – 8.en_US
dc.identifier.citedreferenceBerliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis 1992; 3: 465 – 8.en_US
dc.identifier.citedreference11  Clinical Practice Guideline No. 1: acute pain management: operative or medical procedures and trauma. Rockville (MD): US Department of Health and Human Services. Agency for Health Care Policy and Research; 1993. AHCPR Publication No. 92–0023. [cited 1993]en_US
dc.identifier.citedreferenceBolton-Maggs PH, Perry DJ, Chalmers EA et al. The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 2004; 10: 593 – 628.en_US
dc.identifier.citedreferenceAcharya S et al. Rare bleeding disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248 – 56.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2516.2006.01271.x.pdf
Size:
119.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.